Correspondence to letter to the editor 2 on "Glucagon-like peptide 1 receptor agonist and reduced liver and non-liver complications in adults with type 2 diabetes and metabolic dysfunction-associated steatotic liver disease: a target trial emulation study".
사설/논평
0/5 보강
APA
Mao X, Nguyen MH (2026). Correspondence to letter to the editor 2 on "Glucagon-like peptide 1 receptor agonist and reduced liver and non-liver complications in adults with type 2 diabetes and metabolic dysfunction-associated steatotic liver disease: a target trial emulation study".. Clinical and molecular hepatology, 32(2), e249-e250. https://doi.org/10.3350/cmh.2025.0884
MLA
Mao X, et al.. "Correspondence to letter to the editor 2 on "Glucagon-like peptide 1 receptor agonist and reduced liver and non-liver complications in adults with type 2 diabetes and metabolic dysfunction-associated steatotic liver disease: a target trial emulation study".." Clinical and molecular hepatology, vol. 32, no. 2, 2026, pp. e249-e250.
PMID
40825718
같은 제1저자의 인용 많은 논문 (5)
- A Novel Way for Upper Eyelid Rejuvenation by Combination of Local Fat-Fascia-Muscle Flap Repositioning for Middle-Aged Asian Women.
- GLP-1 receptor agonist-SGLT-2 inhibitor combination and risk of major adverse liver and cardiovascular outcomes in adults with MASLD and type 2 diabetes.
- The disparity and trend of childhood cancer burden in survival perspective: a systematic analysis for the global burden of disease 2021.
- Context-Dependent Dual Roles of the Plexin-B Family in Cancer Progression: Mechanisms and Therapeutic Implications.
- TET2 germline mutation in a patient with sequential lymphoid malignancies: a novel case report.